Testicular Yolk Sac Tumor
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Testicular Yolk Sac Tumor

What is the definition of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor is a subtype of testicular cancer that most commonly occurs in the testicles of young and middle-age men. While the exact cause is not well understood, some risk factors have been determined, such as undescended testicle, abnormal testicle development, smoking, exposure to some chemicals, family history of testicular cancer, HIV infection, and Down syndrome.
What are the symptoms of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor may have no symptoms or appear as a painless mass in the testes. If symptoms occur, they may include discomfort or pain, or a sense of heaviness in the scrotum, lower back of abdominal pain, an enlarged testicle, or an overgrowth of male breast tissue. The cancer may spread to other parts of the body.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Testicular Yolk Sac Tumor?
Treatment for testicular yolk sac cancer depends on how far the cancer has spread and includes surgery (removal of the testicle), radiation therapy, and chemotherapy. Testicular yolk sac cancer is highly treatable and has a high rate of success. Testicular cancer can be detected early by performing a monthly testicular self-examination.
Who are the top Testicular Yolk Sac Tumor Local Doctors?
Distinguished in Testicular Yolk Sac Tumor
Distinguished in Testicular Yolk Sac Tumor
Referral may be required

Intermountain Health West End Clinic Gynecologic Oncology

602 Henry Chapple Street, 
Billings, MT 
Experience:
19+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Petersen was born and raised in Arvada, Colorado. She earned her undergraduate degree from the University of Colorado - Boulder and her Doctor of Medicine from the University of Colorado Health Sciences Center in Denver. Dr. Petersen completed an Internal Medicine Internship with the University of Utah – Salt Lake City and an Obstetrics and Gynecology Residency with Banner Good Samaritan Medical Center in Phoenix, Arizona. She completed a Gynecologic Oncology Fellowship with the University of California, Davis Medical Center. A board-certified provider, Dr. Petersen’s clinical interests include treating and preventing cervical, endometrial, ovarian, vaginal, and vulvar cancers, targeted treatments, minimally invasive surgery, complementary and alternative medicine incorporation into Western Medicine, and holistic oncology care.“I will be with you during the hard times and celebrate the successes. You will be cared for. I am passionate about shared decision-making. Empowering you with as much information as you would like and any additional information I think you should know. I believe in Individualized patient care and listening to what my patients need.”When not in the office, Dr. Petersen enjoys spending her time in the mountains with her family. Dr. Petersen is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Ovarian Carcinosarcoma, Colonoscopy, and Bladder Reconstruction. Dr. Petersen is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Petersen is currently accepting new patients.

Distinguished in Testicular Yolk Sac Tumor
Distinguished in Testicular Yolk Sac Tumor
Referral may be required

Avera Medical Group Gynecologic Oncology — Prairie Center

1000 E 23rd St, Suite 350, 
Sioux Falls, SD 
Languages Spoken:
English
Offers Telehealth

Luis A. Rojas, MD, provides gynecologic oncology services at Avera Medical Group Gynecologic Oncology in Sioux Falls, SD. Dr. Rojas is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Malignant Mixed Mullerian Tumor, Virilizing Ovarian Tumor, Hysterectomy, and Oophorectomy. Dr. Rojas is board certified in American Board Of Obstetrics And Gynecology; Board Certified In Gynecologic Oncology.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Testicular Yolk Sac Tumor
Distinguished in Testicular Yolk Sac Tumor
Referral may be required

Avera Medical Group Gynecologic Oncology — Prairie Center

1000 E 23rd St, Suite 350, 
Sioux Falls, SD 
Languages Spoken:
English
Offers Telehealth

Michael Bidus, MD, provides gynecologic oncologic services at Avera Medical Group Gynecologic Oncology in Sioux Falls, SD. Dr. Bidus is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Oophorectomy, and Splenectomy. Dr. Bidus is board certified in American Board Of Obstetrics And Gynecology American Board Of Obstetrics And Gynecology, Subspecialty In Gynecologic Oncology.

What are the latest Testicular Yolk Sac Tumor Clinical Trials?
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Selected Advanced or Metastatic Solid Tumors

Summary: This is a first-in-human (FIH) clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of BGB-B2033 administered as monotherapy and in combination with tislelizumab, with or without bevacizumab. The study will enroll participants with locally advanced or metastatic hepatocellular carcinoma (HCC), alpha-fetoprotein (AFP)-pr...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors

Summary: This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of t...